A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells.
Genetically engineered T lymphocytes are a promising option for cancer therapy. Prior to adoptive transfer they have to be expanded in vitro to reach therapeutically sufficient numbers. So far, no universal method exists for selective in vitro expansion of engineered T lymphocytes. In order to overc...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/f142152a744f4caf9d7376f363460801 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:f142152a744f4caf9d7376f363460801 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:f142152a744f4caf9d7376f3634608012021-11-18T08:24:58ZA novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells.1932-620310.1371/journal.pone.0093745https://doaj.org/article/f142152a744f4caf9d7376f3634608012014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24699869/?tool=EBIhttps://doaj.org/toc/1932-6203Genetically engineered T lymphocytes are a promising option for cancer therapy. Prior to adoptive transfer they have to be expanded in vitro to reach therapeutically sufficient numbers. So far, no universal method exists for selective in vitro expansion of engineered T lymphocytes. In order to overcome this problem and for proof of concept we incorporated a novel unique peptide sequence of ten amino acids as epitope (E-Tag) into the binding domains of two novel chimeric antigen receptors (ECARs) directed against either prostate stem cell antigen (PSCA) for the treatment of prostate cancer (PCa) or CD33 for the treatment of acute myeloide leukemia (AML). The epitope tag then was utilized for expanding ECAR engrafted T cells by triggering the modified T cells via a monoclonal antibody directed against the E-Tag (Emab). Moreover, the E-Tag served as an efficient selection epitope for immunomagnetic isolation of modified T cells to high purity. ECAR engrafted T cells were fully functional and mediated profound anti-tumor effects in the respective models of PCa or AML both in vitro and in vivo. The method can be integrated straightforward into clinical protocols to improve therapeutic efficiency of tumor treatment with CAR modified T lymphocytes.Marc CartellieriStefanie KoristkaClaudia ArndtAnja FeldmannSlava StamovaMalte von BoninKatrin TöpferThomas KrügerMathias GeibIrene MichalkAchim TemmeMartin BornhäuserDirk LindemannGerhard EhningerMichael P BachmannPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 4, p e93745 (2014) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Marc Cartellieri Stefanie Koristka Claudia Arndt Anja Feldmann Slava Stamova Malte von Bonin Katrin Töpfer Thomas Krüger Mathias Geib Irene Michalk Achim Temme Martin Bornhäuser Dirk Lindemann Gerhard Ehninger Michael P Bachmann A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells. |
| description |
Genetically engineered T lymphocytes are a promising option for cancer therapy. Prior to adoptive transfer they have to be expanded in vitro to reach therapeutically sufficient numbers. So far, no universal method exists for selective in vitro expansion of engineered T lymphocytes. In order to overcome this problem and for proof of concept we incorporated a novel unique peptide sequence of ten amino acids as epitope (E-Tag) into the binding domains of two novel chimeric antigen receptors (ECARs) directed against either prostate stem cell antigen (PSCA) for the treatment of prostate cancer (PCa) or CD33 for the treatment of acute myeloide leukemia (AML). The epitope tag then was utilized for expanding ECAR engrafted T cells by triggering the modified T cells via a monoclonal antibody directed against the E-Tag (Emab). Moreover, the E-Tag served as an efficient selection epitope for immunomagnetic isolation of modified T cells to high purity. ECAR engrafted T cells were fully functional and mediated profound anti-tumor effects in the respective models of PCa or AML both in vitro and in vivo. The method can be integrated straightforward into clinical protocols to improve therapeutic efficiency of tumor treatment with CAR modified T lymphocytes. |
| format |
article |
| author |
Marc Cartellieri Stefanie Koristka Claudia Arndt Anja Feldmann Slava Stamova Malte von Bonin Katrin Töpfer Thomas Krüger Mathias Geib Irene Michalk Achim Temme Martin Bornhäuser Dirk Lindemann Gerhard Ehninger Michael P Bachmann |
| author_facet |
Marc Cartellieri Stefanie Koristka Claudia Arndt Anja Feldmann Slava Stamova Malte von Bonin Katrin Töpfer Thomas Krüger Mathias Geib Irene Michalk Achim Temme Martin Bornhäuser Dirk Lindemann Gerhard Ehninger Michael P Bachmann |
| author_sort |
Marc Cartellieri |
| title |
A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells. |
| title_short |
A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells. |
| title_full |
A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells. |
| title_fullStr |
A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells. |
| title_full_unstemmed |
A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells. |
| title_sort |
novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human t cells. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2014 |
| url |
https://doaj.org/article/f142152a744f4caf9d7376f363460801 |
| work_keys_str_mv |
AT marccartellieri anovelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT stefaniekoristka anovelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT claudiaarndt anovelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT anjafeldmann anovelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT slavastamova anovelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT maltevonbonin anovelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT katrintopfer anovelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT thomaskruger anovelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT mathiasgeib anovelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT irenemichalk anovelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT achimtemme anovelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT martinbornhauser anovelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT dirklindemann anovelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT gerhardehninger anovelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT michaelpbachmann anovelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT marccartellieri novelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT stefaniekoristka novelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT claudiaarndt novelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT anjafeldmann novelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT slavastamova novelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT maltevonbonin novelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT katrintopfer novelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT thomaskruger novelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT mathiasgeib novelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT irenemichalk novelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT achimtemme novelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT martinbornhauser novelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT dirklindemann novelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT gerhardehninger novelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells AT michaelpbachmann novelexvivoisolationandexpansionprocedureforchimericantigenreceptorengraftedhumantcells |
| _version_ |
1718421836086116352 |